Isaac Subirana1,2, Anna Camps-Vilaró1,2, Roberto Elosua2,3,4, Jaume Marrugat1,2, Helena Tizón-Marcos2,5,6, Ivan Palomo7, Irene R Dégano1,2,3. 1. REGICOR Study Group, Department of Epidemiology and Public Health, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. 2. Consorcio de Investigación Biomédica en Red, Cardiovascular Diseases, Instituto de Salud Carlos III (ISCIII), Madrid, Spain. 3. Department of Medicine, University of Vic-Central University of Catalonia (Uvic-UCC), Vic, Spain. 4. Cardiovascular Epidemiology and Genetics Group, Department of Epidemiology and Public Health, IMIM, Barcelona, Spain. 5. Cardiology Department, Hospital del Mar, Barcelona, Spain. 6. Biomedical Research in Heart Diseases Group, Department of Translational Clinical Research, IMIM, Barcelona, Spain. 7. Department of Clinical Biochemistry and Immunohematology, Thrombosis Research Center, Faculty of Health Sciences, Medical Technology School, Talca, Chile.
Abstract
Background and Aims: Cardiovascular (CV) risk functions are the recommended tool to identify high-risk individuals. However, their discrimination ability is not optimal. While the effect of biomarkers in CV risk prediction has been extensively studied, there are no data on CV risk functions including time-dependent covariates together with other variables. Our aim was to examine the effect of including time-dependent covariates, competing risks, and treatments in coronary risk prediction. Methods: Participants from the REGICOR population cohorts (North-Eastern Spain) aged 35-74 years without previous history of cardiovascular disease were included (n = 8470). Coronary and stroke events and mortality due to other CV causes or to cancer were recorded during follow-up (median = 12.6 years). A multi-state Markov model was constructed to include competing risks and time-dependent classical risk factors and treatments (2 measurements). This model was compared to Cox models with basal measurement of classical risk factors, treatments, or competing risks. Models were cross-validated and compared for discrimination (area under ROC curve), calibration (Hosmer-Lemeshow test), and reclassification (categorical net reclassification index). Results: Cancer mortality was the highest cumulative-incidence event. Adding cholesterol and hypertension treatment to classical risk factors improved discrimination of coronary events by 2% and reclassification by 7-9%. The inclusion of competing risks and/or 2 measurements of risk factors provided similar coronary event prediction, compared to a single measurement of risk factors. Conclusion: Coronary risk prediction improves when cholesterol and hypertension treatment are included in risk functions. Coronary risk prediction does not improve with 2 measurements of covariates or inclusion of competing risks.
Background and Aims: Cardiovascular (CV) risk functions are the recommended tool to identify high-risk individuals. However, their discrimination ability is not optimal. While the effect of biomarkers in CV risk prediction has been extensively studied, there are no data on CV risk functions including time-dependent covariates together with other variables. Our aim was to examine the effect of including time-dependent covariates, competing risks, and treatments in coronary risk prediction. Methods: Participants from the REGICOR population cohorts (North-Eastern Spain) aged 35-74 years without previous history of cardiovascular disease were included (n = 8470). Coronary and stroke events and mortality due to other CV causes or to cancer were recorded during follow-up (median = 12.6 years). A multi-state Markov model was constructed to include competing risks and time-dependent classical risk factors and treatments (2 measurements). This model was compared to Cox models with basal measurement of classical risk factors, treatments, or competing risks. Models were cross-validated and compared for discrimination (area under ROC curve), calibration (Hosmer-Lemeshow test), and reclassification (categorical net reclassification index). Results: Cancer mortality was the highest cumulative-incidence event. Adding cholesterol and hypertension treatment to classical risk factors improved discrimination of coronary events by 2% and reclassification by 7-9%. The inclusion of competing risks and/or 2 measurements of risk factors provided similar coronary event prediction, compared to a single measurement of risk factors. Conclusion: Coronary risk prediction improves when cholesterol and hypertension treatment are included in risk functions. Coronary risk prediction does not improve with 2 measurements of covariates or inclusion of competing risks.
Authors: Jaume Marrugat; Joan Vila; José Miguel Baena-Díez; María Grau; Joan Sala; Rafel Ramos; Isaac Subirana; Montserrat Fitó; Roberto Elosua Journal: Rev Esp Cardiol Date: 2011-04-08 Impact factor: 4.753
Authors: Jaume Marrugat; Isaac Subirana; Rafel Ramos; Joan Vila; Alejandro Marín-Ibañez; María Jesús Guembe; Fernando Rigo; María José Tormo Díaz; Conchi Moreno-Iribas; Joan Josep Cabré; Antonio Segura; José Miguel Baena-Díez; Agustín Gómez de la Cámara; José Lapetra; María Grau; Miquel Quesada; María José Medrano; Paulino González Diego; Guiem Frontera; Diana Gavrila; Eva Ardanaz Aicua; Josep Basora; José María García; Manuel García-Lareo; José Antonio Gutierrez; Eduardo Mayoral; Joan Sala; Ralph D'Agostino; Roberto Elosua Journal: Prev Med Date: 2014-01-09 Impact factor: 4.018
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Shona Livingstone; Daniel R Morales; Peter T Donnan; Katherine Payne; Alexander J Thompson; Ji-Hee Youn; Bruce Guthrie Journal: Lancet Healthy Longev Date: 2021-06